Head Of Novartis Foundation Discusses Efforts To Address Leprosy

Health Affairs: One Step Closer To Ending Leprosy
Ann Aerts, head of the Novartis Foundation, discusses the foundation’s efforts to address leprosy, highlighting the leprosy post-exposure prophylaxis (LPEP) initiative launched in 2014 as an approach to case detection and preventive treatment. Aerts writes, “We would encourage every country to follow the WHO guidelines and implement this approach as the international standard” (1/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.